Microbes, Clinical trials, Drug Discovery, and Vaccine Development: The Current Perspectives
Because of the frequent emergence of novel microbial species and the re-emergence of genetic variants of hitherto known microbes, the global healthcare system, and human health has been thrown into jeopardy. Also, certain microbes that possess the ability to develop multi-drug resistance (MDR) have...
Enregistré dans:
Auteurs principaux: | Venkataramana Kandi, Tarun Kumar Suvvari, Sabitha Vadakedath, Vikram Godishala |
---|---|
Format: | article |
Langue: | EN ID |
Publié: |
Institute for Researches and Community Services Universitas Muhammadiyah Palangkaraya
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3bf383f07f1444fe90c3cc054d9d84e5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Potential Use of Aptamers in The Process of Drug Development
par: Tooba Gholikhani, et autres
Publié: (2021) -
Bioassay Guided Fractionation of Marine Streptomyces sp. GMY01 and Antiplasmodial Assay using Microscopic and Flow Cytometry Method
par: Ema Damayanti, et autres
Publié: (2020) -
Natural Bioactive Cyclopeptides from Microbes as Promising Anticancer Drug Leads: A Mini-review
par: Linda Sukmarini
Publié: (2021) -
Discovery of a Potent Candidate for RET-Specific Non-Small-Cell Lung Cancer—A Combined In Silico and In Vitro Strategy
par: Priyanka Ramesh, et autres
Publié: (2021) - Drug discoveries & therapeutics